Australia markets closed

Alliance Pharma plc (APH.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
34.000.00 (0.00%)
As of 04:35PM BST. Market open.
Currency in GBp

Valuation measures4

Market cap (intra-day) 183.74M
Enterprise value 282.05M
Trailing P/E 32.15
Forward P/E 7.63
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.08
Price/book (mrq)0.66
Enterprise value/revenue 1.66
Enterprise value/EBITDA 22.55

Trading information

Stock price history

Beta (5Y monthly) 0.58
52-week change 3-48.48%
S&P500 52-week change 323.57%
52-week high 373.04
52-week low 30.00
50-day moving average 338.29
200-day moving average 340.86

Share statistics

Avg vol (3-month) 31.03M
Avg vol (10-day) 31.76M
Shares outstanding 5540.4M
Implied shares outstanding 6540.4M
Float 8525.85M
% held by insiders 111.76%
% held by institutions 166.71%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.01
Trailing annual dividend yield 30.04%
5-year average dividend yield 42.12
Payout ratio 41,011.76%
Dividend date 3N/A
Ex-dividend date 422 June 2023
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 June 2023

Profitability

Profit margin -4.15%
Operating margin (ttm)16.21%

Management effectiveness

Return on assets (ttm)2.99%
Return on equity (ttm)-2.46%

Income statement

Revenue (ttm)170.05M
Revenue per share (ttm)0.31
Quarterly revenue growth (yoy)3.30%
Gross profit (ttm)N/A
EBITDA 31.47M
Net income avi to common (ttm)-7.06M
Diluted EPS (ttm)-0.01
Quarterly earnings growth (yoy)-61.00%

Balance sheet

Total cash (mrq)26.11M
Total cash per share (mrq)0.05
Total debt (mrq)124.62M
Total debt/equity (mrq)45.00%
Current ratio (mrq)1.93
Book value per share (mrq)0.51

Cash flow statement

Operating cash flow (ttm)29.08M
Levered free cash flow (ttm)19.15M